Strata Critical Medical reported first-quarter 2026 revenue of $67.4 million [4], representing an 87.4% increase year-over-year [3].
The results signal a period of rapid expansion for the New York-based company as it scales its logistics operations and pursues further acquisitions.
Company executives presented the financial data during a conference call and webcast held on May 6, 2026 [2]. The quarter ended on March 31, 2026 [1]. During the call, the company reiterated its full-year 2026 revenue guidance, projecting a total between $260 million and $275 million [5].
William Heyburn, Co-CEO, CFO and Director, said the company achieved results that exceeded guidance for both revenue and adjusted EBITDA. He said the firm is happy to report another great quarter [6].
Growth was driven by both new acquisitions and internal scaling. The company reported organic logistics growth of 32% year-over-year [7]. This internal growth complements a broader strategy to expand its mergers and acquisitions pipeline [5].
The reported revenue growth of 87.4% [3] is slightly higher than the 87% figure cited in some reports [2], though both indicate a significant surge in quarterly earnings. The company continues to focus on integrating its recent growth, while maintaining its projected financial trajectory for the remainder of the year.
“Strata Critical Medical reported first-quarter 2026 revenue of $67.4 million”
The combination of high organic growth and a robust M&A pipeline suggests Strata Critical Medical is aggressively capturing market share in the critical medical logistics sector. By maintaining its full-year guidance despite a strong start, the company is signaling a sustainable growth trajectory rather than a one-time spike.
